Literature DB >> 6216022

Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines.

P Simpson, A McGrath, S Savion.   

Abstract

The role of hormones and other humoral factors in the regulation of myocardial hypertrophy has been difficult to evaluate. We asked whether myocardial cell hypertrophy could be demonstrated in cultures from the day-old rat ventricle and evaluated the effect of serum concentration and catecholamines on the growth process. Two single-cell preparations were used: serum-supplemented, bromodeoxyuridine-treated cultures and serum-free cultures with transferrin and insulin. Both preparations were characterized by myocardial cell predominance (about 75--80% of total cells) and constant cell numbers. Myocardial cell size was documented by photomicroscopy and quantified by volume (microscopic diameter of suspended cells), surface area (planimetry of attached cells), and total cell protein concentration (Lowry method and cell counts). Growth was also evaluated in pure nonmyocardial cell cultures. In cultures with 5% (vol/vol) serum, myocardial cell size increased 2- to 3-fold over 11 days in culture. Final volume, surface area, and protein concentration were about 3000 micrometer3/cell, 5000 micrometer2/cell, and 1500 pg/cell, respectively. Serum had a dose-related effect on myocardial cell hypertrophy; myocardial cell size increased about 4-fold when serum concentration was increased from 0% to 5% or 10%. Cells maintained in serum-free medium with transferrin and insulin (each 10 microgram/ml) did not hypertrophy, but did remain responsive to the growth-promoting activity of serum. Chronic exposure to isoproterenol or norepinephrine (1 microM) significantly stimulated myocardial cell hypertrophy. This stimulation was dose-related, was not blocked by equimolar propranolol, was not associated with a sustained chronotropic effect, and was more pronounced in the serum-free preparation. In pure cultures of nonproliferating (bromodeoxyuridine-treated) nonmyocardial cells, cell size also increased with time in culture, but variation in serum concentration and addition of norepinephrine had no significant effect on cell size. Myocardial cell hypertrophy occurs in culture and is regulated by variations in the culture medium, including serum, with its contained hormones and growth factors, and catecholamines. The culture preparation can be used to explore the regulation of myocardial cell hypertrophy by nonhemodynamic factors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6216022     DOI: 10.1161/01.res.51.6.787

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  91 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

2.  Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro.

Authors:  K L King; J Lai; J Winer; E Luis; R Yen; J Hooley; P M Williams; J P Mather
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

3.  Serum-free, chemically defined medium to evaluate the direct effects of growth factors and inhibitors on proliferation and function of neonatal rat cardiac muscle cells in culture.

Authors:  T Suzuki; M Ohta; H Hoshi
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

Review 4.  Role of phospholipase Cε in physiological phosphoinositide signaling networks.

Authors:  Alan V Smrcka; Joan Heller Brown; George G Holz
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

Review 5.  Detrimental effects of beta-adrenergic stimulation on beta-adrenoceptors and microtubules in the heart.

Authors:  M Hori; Y Koretsune; H Sato; T Kagiya; A Kitabatake; T Kamada
Journal:  Heart Vessels Suppl       Date:  1991

Review 6.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

7.  Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes.

Authors:  K J Rocha-Singh; N Y Honbo; J S Karliner
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  The CRM1 nuclear export receptor controls pathological cardiac gene expression.

Authors:  Brooke C Harrison; Charles R Roberts; David B Hood; Meghan Sweeney; Jody M Gould; Erik W Bush; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 9.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

10.  CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.

Authors:  Scott M MacDonnell; Jutta Weisser-Thomas; Hajime Kubo; Marie Hanscome; Qinghang Liu; Naser Jaleel; Remus Berretta; Xiongwen Chen; Joan H Brown; Abdel-Karim Sabri; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2009-07-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.